What We're Reading: Page 333
Industry reads hand-picked by our editors
Jun 09, 2016
-
Modern Healthcare
Biopharma plays offense to justify high price tags
-
The Wall Street Journal
Biogen CIO Matt Griffiths no longer with company
-
The Cannabist
Medical marijuana sellers in Canada continue despite crackdown
-
Nurse.com
Pharmaceutical companies continue to hike drug costs
Jun 08, 2016
-
Bloomberg BNA
Pharma deals under a microscope at FTC
-
Medical Marketing & Media
The CIO, reimagined for pharma
-
Chicago Tribune
Avenging Pharma Bro: Vermont demands drug firms justify price hikes
-
Financial Times
Pharma surge boosts UK manufacturing output
Jun 07, 2016
-
Forbes
The world's most reputable pharmaceutical companies in 2016
-
The Clarion-Ledger
US seizes Mississippi properties in pharmaceutical scheme
-
The Motley Fool
These 2 catalysts helped push Galena Biopharma Inc. 31% higher in May
-
IPWatchdog
IP protection critical for biopharma given number, cost and complexity of clinical trials
Jun 06, 2016
Jun 03, 2016
-
EP Vantage
Strimvelis approval could rejuvenate gene therapy arena
-
Washington Post
Stanford researchers ‘stunned’ by stem cell experiment that helped stroke patient walk
-
Bloomberg
Valeant Gets Default Notice Due to Quarterly Filing Delay
-
Reuters
Botswana gets GSK's modern HIV drug in largest ever Africa tender
Previous
